{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:23:00Z","timestamp":1785514980621,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00535-018-01542-w","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T09:15:59Z","timestamp":1547457359000},"page":"218-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science"],"prefix":"10.1007","volume":"54","author":[{"given":"Gurmehr","family":"Brar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6833-2998","authenticated-orcid":false,"given":"Hidekazu","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"1542_CR1","volume-title":"IHME","author":"GBD Compare Data Visualization","year":"2016","unstructured":"GBD Compare Data Visualization. IHME. Washington: University of Washington; 2016."},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD Disease","year":"2017","unstructured":"Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211\u201359.","journal-title":"Lancet"},{"key":"1542_CR3","unstructured":"World Bank Analytical Classifications. 2016."},{"key":"1542_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms17050774","volume":"17","author":"L Calzadilla Bertot","year":"2016","unstructured":"Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016;17:774.","journal-title":"Int J Mol Sci."},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/gast.2002.36572","volume":"123","author":"AJ Sanyal","year":"2002","unstructured":"Sanyal AJ, American Gastroenterological A. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705\u201325.","journal-title":"Gastroenterology"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","volume":"91","author":"ZM Younossi","year":"2012","unstructured":"Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91:319\u201327.","journal-title":"Medicine (Baltimore)."},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","volume":"164","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Kim HJ, Lee KE, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med. 2004;164:2169\u201375.","journal-title":"Arch Intern Med"},{"key":"1542_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/hepr.12648","volume":"46","author":"Y Honda","year":"2016","unstructured":"Honda Y, Yoneda M, Kessoku T, et al. Characteristics of non-obese non-alcoholic fatty liver disease: effect of genetic and environmental factors. Hepatol Res. 2016;46:1011\u20138.","journal-title":"Hepatol Res."},{"key":"1542_CR9","doi-asserted-by":"publisher","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","volume":"20","author":"RN Feng","year":"2014","unstructured":"Feng RN, Du SS, Wang C, et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol. 2014;20:17932\u201340.","journal-title":"World J Gastroenterol"},{"key":"1542_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4103\/2230-8210.113758","volume":"17","author":"R Kumar","year":"2013","unstructured":"Kumar R, Rastogi A, Sharma MK, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab. 2013;17:665\u201371.","journal-title":"Indian J Endocrinol Metab."},{"key":"1542_CR11","doi-asserted-by":"publisher","first-page":"18273","DOI":"10.1073\/pnas.0608537103","volume":"103","author":"KF Petersen","year":"2006","unstructured":"Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1542_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112\u20137.","journal-title":"Ann Intern Med"},{"key":"1542_CR13","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S1542-3565(05)00743-3","volume":"3","author":"CE Ruhl","year":"2005","unstructured":"Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol. 2005;3:1260\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1542_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1365-2036.2009.04141.x","volume":"30","author":"R Loomba","year":"2009","unstructured":"Loomba R, Bettencourt R, Barrett-Connor E. Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharm Ther. 2009;30:1137\u201349.","journal-title":"Aliment Pharm Ther."},{"key":"1542_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/00365520802555991","volume":"44","author":"M Ekstedt","year":"2009","unstructured":"Ekstedt M, Franzen LE, Holmqvist M, et al. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroentero. 2009;44:366\u201374.","journal-title":"Scand J Gastroentero."},{"key":"1542_CR16","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/hep.29055","volume":"65","author":"VH Ajmera","year":"2017","unstructured":"Ajmera VH, Terrault NA, Harrison SA. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017;65:2090\u20139.","journal-title":"Hepatology."},{"key":"1542_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.atherosclerosis.2014.03.001","volume":"234","author":"DH Sinn","year":"2014","unstructured":"Sinn DH, Gwak GY, Cho J, et al. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease. Atherosclerosis. 2014;234:270\u20135.","journal-title":"Atherosclerosis."},{"key":"1542_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol-use disorders identification test (audit)\u2014who collaborative project on early detection of persons with harmful alcohol-consumption. Addiction. 1993;88:791\u2013804.","journal-title":"Addiction"},{"key":"1542_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/MEG.0b013e328328f3ec","volume":"21","author":"HP Cotrim","year":"2009","unstructured":"Cotrim HP, Freitas LA, Alves E, et al. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroen Hepat. 2009;21:969\u201372.","journal-title":"Eur J Gastroen Hepat."},{"key":"1542_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2001.25540","volume":"121","author":"JB Dixon","year":"2001","unstructured":"Dixon JB, Bhathal PS, O\u2019Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91\u2013100.","journal-title":"Gastroenterology"},{"key":"1542_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/liv.12230","volume":"34","author":"HK Kwon","year":"2014","unstructured":"Kwon HK, Greenson JK, Conjeevaram HS. Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease. Liver Int. 2014;34:129\u201335.","journal-title":"Liver Int."},{"key":"1542_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/apt.13067","volume":"41","author":"K Lau","year":"2015","unstructured":"Lau K, Baumeister SE, Lieb W, et al. The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women. Aliment Pharm Ther. 2015;41:467\u201376.","journal-title":"Aliment Pharm Ther."},{"key":"1542_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/S0004-28032012000100015","volume":"49","author":"MR Souza","year":"2012","unstructured":"Souza MR, Diniz Mde F, Medeiros-Filho JE, et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012;49:89\u201396.","journal-title":"Arq Gastroenterol"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.23527","volume":"51","author":"MS Ascha","year":"2010","unstructured":"Ascha MS, Hanouneh IA, Lopez R, et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972\u20138.","journal-title":"Hepatology"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1126\/science.1170803","volume":"324","author":"Y Nakahata","year":"2009","unstructured":"Nakahata Y, Sahar S, Astarita G, et al. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science. 2009;324:654\u20137.","journal-title":"Science"},{"key":"1542_CR26","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.cell.2013.11.034","volume":"155","author":"KL Eckel-Mahan","year":"2013","unstructured":"Eckel-Mahan KL, Patel VR, de Mateo S, et al. Reprogramming of the circadian clock by nutritional challenge. Cell. 2013;155:1464\u201378.","journal-title":"Cell"},{"key":"1542_CR27","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.15252\/embr.201642463","volume":"17","author":"M Murakami","year":"2016","unstructured":"Murakami M, Tognini P, Liu Y, et al. Gut microbiota directs PPARgamma-driven reprogramming of the liver circadian clock by nutritional challenge. EMBO Rep. 2016;17:1292\u2013303.","journal-title":"EMBO Rep"},{"key":"1542_CR28","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.29676","volume":"67","author":"P Hartmann","year":"2018","unstructured":"Hartmann P, Hochrath K, Horvath A, et al. Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology. 2018;67:2150\u201366.","journal-title":"Hepatology"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1172\/JCI90562","volume":"127","author":"AM Yang","year":"2017","unstructured":"Yang AM, Inamine T, Hochrath K, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127:2829\u201341.","journal-title":"J Clin Invest."},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 2012;122:3476\u201389.","journal-title":"J Clin Invest."},{"key":"1542_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1189\/jlb.1212659","volume":"94","author":"D Lippai","year":"2013","unstructured":"Lippai D, Bala S, Petrasek J, et al. Alcohol-induced IL-1beta in the brain is mediated by NLRP3\/ASC inflammasome activation that amplifies neuroinflammation. J Leukoc Biol. 2013;94:171\u201382.","journal-title":"J Leukoc Biol"},{"key":"1542_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/B978-0-12-801284-0.00011-7","volume":"118","author":"G Szabo","year":"2014","unstructured":"Szabo G, Lippai D. Converging actions of alcohol on liver and brain immune signaling. Int Rev Neurobiol. 2014;118:359\u201380.","journal-title":"Int Rev Neurobiol"},{"key":"1542_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.27678","volume":"61","author":"AJ Sanyal","year":"2015","unstructured":"Sanyal AJ, Friedman SL, McCullough AJ, et al. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-US Food and Drug Administration Joint Workshop. Hepatology. 2015;61:1392\u2013405.","journal-title":"Hepatology"},{"key":"1542_CR34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"1542_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/hep.29724","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Loomba R, Rinella ME, et al. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2018;68:361\u201371.","journal-title":"Hepatology"},{"key":"1542_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/jci.insight.95354","volume":"2","author":"T Greuter","year":"2017","unstructured":"Greuter T, Malhi H, Gores GJ, et al. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight. 2017;2:17.","journal-title":"JCI Insight."},{"key":"1542_CR37","doi-asserted-by":"publisher","first-page":"170ra14","DOI":"10.1126\/scitranslmed.3005123","volume":"5","author":"C Lindtner","year":"2013","unstructured":"Lindtner C, Scherer T, Zielinski E, et al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med. 2013;5:170ra14.","journal-title":"Sci Transl Med."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-018-01542-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-01542-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-01542-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T19:19:10Z","timestamp":1578943150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-018-01542-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s00535-018-01542-w","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}